SCHEMBL3058486

SCHEMBL3058486

CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CC(OCC)C(=O)OC(CO)CO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
MAPT P10636 2/20 0.40
FAAH O00519 1/20 0.40
HPGD P15428 1/20 0.40
NR1I2 O75469 1/20 0.38
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
PTGS2 P35354 1/20 0.38
PDE4D Q08499 1/20 0.38
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FFAR1 O14842 1/20 0.33
CYP19A1 P11511 1/20 0.33
RXRA P19793 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3058489 1.00 ALDH1A1 (0.40) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3059059 0.87 ALDH1A1 (0.40) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3059057 0.87 ALDH1A1 (0.40) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL441945 0.83 PTGS2 (0.46) ALDH1A1MAPTHPGDNR1I2PGR
SCHEMBL3226480 0.83 PTGS2 (0.46) ALDH1A1MAPTHPGDNR1I2PGR
SCHEMBL3226490 0.83 PTGS2 (0.46) ALDH1A1MAPTHPGDNR1I2PGR
SCHEMBL3066159 0.80 ALDH1A1 (0.42) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3066157 0.80 ALDH1A1 (0.42) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL3068622 0.79 ALDH1A1 (0.41) ALDH1A1CNR1CNR2MAPTFAAH
SCHEMBL13491259 0.79 ADORA3 (0.50) ALDH1A1CNR1CNR2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267828-A1 DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS PRONOVA BIOPHARMA NORGE AS (NO) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267828-A1 DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS LIPA, LPL, PNLIP ALDH1A1 1114/4885CNR1 584/4885CNR2 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.